Cancer Advisor

Quick Answer: The ROOT Protocol is a tiered, nutraceutical-based cancer-prevention framework developed by Dr. Paul Marik and Dr. Justus Hope. It begins with a three-agent foundation — green tea EGCG, curcumin, and vitamin D3 — and adds omega-3s, berberine, and sulforaphane in higher tiers. The top tier, Root 9, adds the prescription drugs celecoxib, ivermectin, and mebendazole, and is scoped by its own authors to people with hereditary cancer syndromes under specialist supervision, not general use. It is best understood as a supplement escalation ladder layered on top of the diet and lifestyle foundation described in OneDayMD's I-PREVENT Cancer Protocol . Medically reviewed and updated by the OneDayMD Editorial Team | Last updated July 11, 2026 Table of Contents 1. Why Cancer Prevention Needs a Systems-Level Rethink 2. The Metabolic Drivers Screening Doesn't Address 3. The ROOT Protocol: From 3 Agents to 9 4. Root 3 and Root 4: The Foundationa...

Some people may not realize this, but many people have cancer cells in their bodies without presenting much danger. Fortunately, there are some common foods that can cut off cancer cell’s nutrient supply and starve them to death. Autopsies of individuals who died of trauma often reveal microscopic colonies of cancer cells , also known as in situ tumors. Some people call them “disease-free cancers.” For instance, researchers  (NEJM) in Denmark performed autopsies on women aged 40 to 50, who never  (Nature) had cancer during their lifetime, and found that 39 percent of them had small cancerous lesions in their breasts. Only 1 percent of women in this age group would be diagnosed with breast cancer. Update: Press Pulse Protocol 2.0 (2026) : A Complete Immunometabolic Strategy for Cancer Control Examination of some men in their 60s showed that 46 percent of them had histological evidence of prostate cancer, which is consistent with the findings of the autopsy study. However, the ...

Quick Answer Dr. Thomas Seyfried , a biologist at Boston College, argues that cancer is primarily a mitochondrial metabolic disease rather than a genetic one. His core treatment framework — the Press-Pulse protocol — pairs a therapeutic ketogenic diet that restricts glucose and glutamine (the "press") with pulsed adjuncts like glutaminase-inhibiting drugs, hyperbaric oxygen, or fasting (the "pulse"). Mechanistic and preclinical evidence is strong; human evidence is a mix of promising case reports and small, mostly inconclusive trials — including a 2026 randomized pancreatic cancer trial that showed a survival trend without reaching statistical significance. Most integrative oncologists treat metabolic therapy as a physician-supervised adjunct to, not a replacement for, standard cancer care. In This Guide Who Is Thomas Seyfried? The Case Against Standard-of-Care Statistics Diet and Cancer: Why Food Isn't Neutral Cutting Off Cancer's Fu...